Pharmacokinetics of metioprim in normal subjects and patients with impaired renal function.
The pharmacokinetics of metioprim, a new competitive inhibitor of bacterial dihydrofolate reductases, were studied after a single oral dose of 100 mg in two young healthy subjects, four elderly volunteers, and eight patients with impaired renal function. The pharmacokinetic parameters of unchanged m...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1983
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185136/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6638987/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.2.190 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|